Mirae Asset Global Investments’s Alder Biopharmaceuticals ALDR Stock Holding History

Mirae Asset Global Investments’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-37,401	Closed	-$778K	–	685
2017 Q1	$778K	Sell	37,401 -8,570	-19%	-$190K	0.01%	398
2016 Q4	$956K	Buy	45,971 +24,699	+116%	+$642K	0.02%	333
2016 Q3	$697K	Buy	21,272 +18	+0.1%	+$548	0.01%	389
2016 Q2	$531K	Sell	21,254 -13,478	-39%	-$365K	0.01%	392
2016 Q1	$851K	Sell	34,732 -250	-0.7%	-$5.79K	0.02%	343
2015 Q4	$1.16M	Sell	34,982 -18,552	-35%	-$627K	0.04%	300
2015 Q3	$1.75M	Buy	53,534 +17,659	+49%	+$751K	0.07%	216
2015 Q2	$1.9M	Buy	35,875 +10,775	+43%	+$392K	0.06%	216
2015 Q1	$724K	Buy	+25,100	New	+$689K	0.02%	348

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments's ALDR Position: Q2 2017 in Review

Mirae Asset Global Investments sold out of Alder Biopharmaceuticals (ALDR) in Q2 2017, closing a stake of 37,401 shares — an estimated $778K sold.

Mirae Asset Global Investments first reported a position in ALDR in Q1 2015 and held it in 9 quarters. The position peaked at $1.9M in Q2 2015. 128 funds tracked by Wall St. Rank hold ALDR as of Q2 2017.

Mirae Asset Global Investments reported no remaining Alder Biopharmaceuticals position as of Q2 2017 after selling out during the quarter.
Mirae Asset Global Investments sold 37,401 Alder Biopharmaceuticals shares in Q2 2017, an estimated $778K.
Mirae Asset Global Investments first reported a position in Alder Biopharmaceuticals in Q1 2015 and held it in 9 quarters.
Mirae Asset Global Investments's Alder Biopharmaceuticals position peaked at $1.9M in Q2 2015.
128 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2017.

Based on Mirae Asset Global Investments's 13F filing for Q2 2017, filed 14 Aug 2017.